W

Wanbury Limited

WANBURY
Market snapshot · 2026-08-11 06:08 UTC

237.50

₹-8.65 (-3.51%)

MARKET CAP

₹829.81 Cr

STOCK P/E

12.2x

52W HIGH

₹358.85

52W LOW

₹161.50

BOOK VALUE

₹48.32

EPS

₹19.43

ROE

SECTOR

Health Care

DEBT/EQUITY

VOLUME

2.58L

P/B RATIO

4.92x

PEG RATIO

Sector

Health Care

Themes

Pharmaceuticals
₹332.20₹293.62₹255.04₹216.45₹177.87VolumeAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Valuation Metrics

Trading 4.5% above historical median. Valuation is stable — currently in the overvalued zone (z-score: +0.5). Confidence: 68%.

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

P/E
Overvalued

5Y Average

8.02

Current

12.67

Overvalued

13.38

Undervalued

8.12

P/S
Strongly Overvalued

5Y Average

1.46

Current

2.31

Overvalued

1.68

Undervalued

1.24

P/B
Strongly Undervalued

5Y Average

10.34

Current

5.09

Overvalued

15.00

Undervalued

7.10

Peers & Comparison

Sector: Healthcare

No peer data available for this company.
WHY THESE PEERS

Peers are filtered to companies with market cap between 0.2x and 5.0x of the primary company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹165 CrMar 2026

Latest net profit

₹22 CrMar 2026

Latest EPS

₹7.26Mar 2026

Net margin

16.2%Mar 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.0%5.0%10.0%15.0%20.0%0.00 Cr45 Cr90 Cr135 Cr180 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.00 Cr45 Cr90 Cr135 Cr180 Cr₹0₹2₹4₹6₹8
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOtheradjustmentsOperatingprofitOther incomeInterestOtheradjustmentsProfitbefore taxTax & otherOtheradjustmentsNet Profit0.00 Cr45 Cr90 Cr135 Cr180 Cr

Latest reported period: Mar 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Annual view
Mar 2025Sep 2025Mar 2026-200 Cr0.00 Cr200 Cr400 Cr600 Cr
  • Debt
  • Free cash flow
  • Cash & equivalents

Results

Sales

₹165 Cr

-4.3%

Net Profit

₹22 Cr

+7.2%

EBITDA

₹26 Cr

-15.9%

EPS

₹7.26

+17.5%
MetricDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales172163160162165
Expenses146142138140138
Operating Profit2621222327
OPM %15.26%12.75%13.79%14.13%16.18%
Other Income20000
Interest98778
Depreciation34443
Profit before tax1914151615
Tax %-6.31%0.85%-0.13%0.67%-43.08%
Net Profit2013151622
EPS in Rs6.184.124.584.527.26

All values in ₹ Crores unless otherwise stated. Source: Company filings.

Shareholding Pattern

HolderMar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters39.76%39.63%39.63%43.07%43.02%
FII1.55%1.59%0.80%0.72%0.59%
Public41.78%42.07%43.84%41.28%42.16%
Others16.91%16.71%15.73%14.93%14.23%
Mar 2026
Promoters
FII
Public
Others